XNYS · Laboratory Analytical Instruments · S&P 500
$301.90
+$0.19 (+0.06%) today
Open $301.71 High $307.49 Low $300.16 Vol 454K Avg $303.31
52-week price range
Price is 27.5% above its 52-week low and 12.0% below its 52-week high. Trading in the upper half of its annual range — closer to the peak than the base.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.